Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.

about

Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.

Item

http://www.wikidata.org/entity/Q49676839

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@en

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@nl

type

Item

label

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@en

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@nl

prefLabel

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@en

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@nl

P1476

Intravitreal bevacizumab in tr ...... uberculous retinal vasculitis.

@en

P2093

Nattaporn Tesavibul

http://www.w3.org/2001/XMLSchema#string

Supinda Leeamornsiri

http://www.w3.org/2001/XMLSchema#string

Sutasinee Boonsopon

http://www.w3.org/2001/XMLSchema#string

Theeratach Sriboonnark

http://www.w3.org/2001/XMLSchema#string

P2860

Ocular tuberculosis: current perspectives

Treatment of tuberculosis

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report.

Ischemic retinal vasculitis and its management.

Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization.

Intraocular tuberculosis--an update.

Bevacizumab (Avastin) for the treatment of ocular disease.

Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.

P304

1627-1629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18240/IJO.2017.10.25

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pitipol Choopong

P577

2017-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29062788

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

bevacizumab

P932

5638990

http://www.w3.org/2001/XMLSchema#string